High materiality8/10
Intensity Therapeutics price target lowered to $15 from $30 at Alliance Global
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Alliance Global analyst target update for INTS: price target lowered to $15 from $30; current price around $4.20, signaling upside potential.
- INTS target $15 vs price $4.20
- Upside potential remains substantial with target above current price
- Analyst update implies strong upside for INTS
Key facts
- 01
Target: $15
- 02
Posted price: $4.2
- 03
Analyst firm: Industrial Alliance Securities
- 04
Analyst: James Molloy
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.